These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
620 related articles for article (PubMed ID: 25226478)
1. Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis. Castellucci LA; Cameron C; Le Gal G; Rodger MA; Coyle D; Wells PS; Clifford T; Gandara E; Wells G; Carrier M JAMA; 2014 Sep; 312(11):1122-35. PubMed ID: 25226478 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses. Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of Apixaban Versus Other Oral Anticoagulants for the Initial Treatment of Venous Thromboembolism and Prevention of Recurrence. Lanitis T; Leipold R; Hamilton M; Rublee D; Quon P; Browne C; Cohen AT Clin Ther; 2016 Mar; 38(3):478-93.e1-16. PubMed ID: 26922297 [TBL] [Abstract][Full Text] [Related]
4. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Akl EA; Rohilla S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann HJ Cochrane Database Syst Rev; 2008 Jan; (1):CD006649. PubMed ID: 18254108 [TBL] [Abstract][Full Text] [Related]
5. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Akl EA; Kahale L; Neumann I; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H Cochrane Database Syst Rev; 2014 Jun; (6):CD006649. PubMed ID: 24945634 [TBL] [Abstract][Full Text] [Related]
6. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H Cochrane Database Syst Rev; 2011 Jun; (6):CD006649. PubMed ID: 21678360 [TBL] [Abstract][Full Text] [Related]
7. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H Cochrane Database Syst Rev; 2011 Feb; (2):CD006649. PubMed ID: 21328285 [TBL] [Abstract][Full Text] [Related]
8. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410 [TBL] [Abstract][Full Text] [Related]
9. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H Cochrane Database Syst Rev; 2011 Apr; (4):CD006649. PubMed ID: 21491395 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach. Rollins BM; Silva MA; Donovan JL; Kanaan AO Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis. Castellucci LA; Cameron C; Le Gal G; Rodger MA; Coyle D; Wells PS; Clifford T; Gandara E; Wells G; Carrier M BMJ; 2013 Aug; 347():f5133. PubMed ID: 23996149 [TBL] [Abstract][Full Text] [Related]
12. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Andras A; Sala Tenna A; Crawford F Cochrane Database Syst Rev; 2012 Oct; 10():CD002001. PubMed ID: 23076894 [TBL] [Abstract][Full Text] [Related]
13. Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis. Gómez-Outes A; Terleira-Fernández AI; Lecumberri R; Suárez-Gea ML; Vargas-Castrillón E Thromb Res; 2014 Oct; 134(4):774-82. PubMed ID: 25037495 [TBL] [Abstract][Full Text] [Related]
14. Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer. Akl EA; Barba M; Rohilla S; Terrenato I; Sperati F; Muti P; Schünemann HJ Cochrane Database Syst Rev; 2008 Apr; (2):CD006650. PubMed ID: 18425959 [TBL] [Abstract][Full Text] [Related]
15. Direct oral anticoagulants for venous thromboembolism in cancer patients: a systematic review and network meta-analysis. Wu S; Lv M; Chen J; Jiang S; Chen M; Fang Z; Zeng Z; Qian J; Xu W; Guan C; Zhang J Support Care Cancer; 2022 Dec; 30(12):10407-10420. PubMed ID: 36318341 [TBL] [Abstract][Full Text] [Related]
16. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis. Caldeira D; Rodrigues FB; Barra M; Santos AT; de Abreu D; Gonçalves N; Pinto FJ; Ferreira JJ; Costa J Heart; 2015 Aug; 101(15):1204-11. PubMed ID: 26037103 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences. Lanitis T; Leipold R; Hamilton M; Rublee D; Quon P; Browne C; Cohen AT BMC Health Serv Res; 2017 Jan; 17(1):74. PubMed ID: 28114939 [TBL] [Abstract][Full Text] [Related]
18. Anticoagulant selection for patients with VTE-Evidence from a systematic literature review of network meta-analyses. Cohen AT; Berger SE; Milenković D; Hill NR; Lister S Pharmacol Res; 2019 May; 143():166-177. PubMed ID: 30905806 [TBL] [Abstract][Full Text] [Related]
19. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. Akl EA; Labedi N; Barba M; Terrenato I; Sperati F; Muti P; Schünemann H Cochrane Database Syst Rev; 2011 Jun; (6):CD006650. PubMed ID: 21678361 [TBL] [Abstract][Full Text] [Related]
20. Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism. Chen DY; Tseng CN; Hsieh MJ; Lan WC; Chuang CK; Pang ST; Chen SW; Chen TH; Chang SH; Hsieh IC; Chu PH; Wen MS; Chen JS; Chang JW; See LC; Huang WK JAMA Netw Open; 2021 Feb; 4(2):e2036304. PubMed ID: 33533929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]